section name header

Pronunciation ⬇

pin-ah-VEER-ee-um

Classifications ⬆ ⬇

Therapeutic Classification: anti irritable bowel syndrome agents

Pharmacologic Classification: calcium channel blockers

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Acts as a calcium channel blocker with specific selectivity for intestinal smooth muscle.
  • Relaxes GI (mainly colon) and biliary tracts; inhibits colonic motor response to food/pharmacologic stimulation.
Therapeutic effects:
  • Decreased symptoms of IBS.

Pharmacokinetics ⬆ ⬇

Absorption: Poorly absorbed (1–10%).

Distribution: Distributes selectively to digestive tract.

Protein Binding: 97%.

Metabolism/Excretion: Minimal enterohepatic cycling; eliminated almost entirely in feces. Some metabolism.

Half-Life: 1.5 hr.

Time/Action Profile ⬆ ⬇

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown1 hrunknown

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

GI: constipation, diarrhea, distention, dry mouth, epigastric pain/fullness, esophageal irritation, nausea

Derm: rash

Neuro: drowsiness, headache, vertigo

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

Canadian Brand Names ⬆

Dicetel